Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 4
2009 2
2012 1
2013 2
2014 2
2015 1
2016 1
2017 1
2021 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Innate Immune Gene Polymorphisms and COVID-19 Prognosis.
Bakaros E, Voulgaridi I, Paliatsa V, Gatselis N, Germanidis G, Asvestopoulou E, Alexiou S, Botsfari E, Lygoura V, Tsachouridou O, Mimtsoudis I, Tseroni M, Sarrou S, Mouchtouri VA, Dadouli K, Kalala F, Metallidis S, Dalekos G, Hadjichristodoulou C, Speletas M. Bakaros E, et al. Among authors: kalala f. Viruses. 2023 Aug 22;15(9):1784. doi: 10.3390/v15091784. Viruses. 2023. PMID: 37766191 Free PMC article.
The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination.
Speletas M, Bakaros E, Peristeri AM, Voulgaridi I, Sarrou S, Paliatsa V, Nasika A, Tseroni M, Anagnostopoulos L, Theodoridou K, Kalala F, Theodoridou A, Mouchtouri BA, Tsiodras S, Eibel H, Hadjichristodoulou C. Speletas M, et al. Among authors: kalala f. Int J Mol Sci. 2022 Nov 14;23(22):14056. doi: 10.3390/ijms232214056. Int J Mol Sci. 2022. PMID: 36430533 Free PMC article.
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
Kakkas I, Tsinti G, Kalala F, Farmaki E, Kourakli A, Kapousouzi A, Dimou M, Kalaitzidou V, Sevdali E, Peristeri AM, Tsiouma G, Patiou P, Papadimitriou E, Vassilakopoulos TP, Panayiotidis P, Kioumi A, Symeonidis A, Speletas M. Kakkas I, et al. Among authors: kalala f. Medicina (Kaunas). 2021 Aug 16;57(8):827. doi: 10.3390/medicina57080827. Medicina (Kaunas). 2021. PMID: 34441032 Free PMC article.
Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination.
Speletas M, Voulgaridi I, Bogogiannidou Z, Sarrou S, Kyritsi MA, Theodoridou A, Dadouli K, Matziri A, Vontas A, Pappa D, Konstantinou AK, Tsigalou C, Kalala F, Mouchtouri VA, Hadjichristodoulou C. Speletas M, et al. Among authors: kalala f. Vaccines (Basel). 2023 Dec 21;12(1):12. doi: 10.3390/vaccines12010012. Vaccines (Basel). 2023. PMID: 38276671 Free PMC article.
Foxp3 expression in human cancer cells.
Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, Kerenidi T, Barda AK, Gourgoulianis KI, Germenis AE. Karanikas V, et al. Among authors: kalala f. J Transl Med. 2008 Apr 22;6:19. doi: 10.1186/1479-5876-6-19. J Transl Med. 2008. PMID: 18430198 Free PMC article.
Measles Immunity Status of Greek Population after the Outbreak in 2017-2018: Results from a Seroprevalence National Survey.
Nasika A, Bogogiannidou Z, Mouchtouri VA, Dadouli K, Kyritsi MA, Vontas A, Voulgaridi I, Tsinaris Z, Kola K, Matziri A, Lianos AG, Kalala F, Petinaki E, Speletas M, Hadjichristodoulou C. Nasika A, et al. Among authors: kalala f. Vaccines (Basel). 2023 Jul 9;11(7):1220. doi: 10.3390/vaccines11071220. Vaccines (Basel). 2023. PMID: 37515036 Free PMC article.
An adult patient with systemic mastocytosis and B-acute lymphoblastic leukemia.
Iliakis T, Rougkala N, Diamantopoulos PT, Papadopoulou V, Kalala F, Zervakis K, Giannakopoulou N, Chatzinikolaou P, Levidou G, Lakiotaki E, Korkolopoulou P, Patsouris E, Variami E, Viniou NA. Iliakis T, et al. Among authors: kalala f. Case Rep Med. 2014;2014:526129. doi: 10.1155/2014/526129. Epub 2014 Nov 6. Case Rep Med. 2014. PMID: 25431599 Free PMC article.
Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.
Diamantopoulos PT, Polonyfi K, Sofotasiou M, Papadopoulou V, Kalala F, Iliakis T, Zervakis K, Tsilimidos G, Kouzis P, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Vayopoulos G, Kollia P, Pangalis G, Viniou NA. Diamantopoulos PT, et al. Among authors: kalala f. Anticancer Res. 2013 Dec;33(12):5693-8. Anticancer Res. 2013. PMID: 24324119
22 results